Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

United Therapeutics acquires Anheuser-Busch plant

PUBLIC · UTHRSep 03, 2026•about 6 hours ago

Acquiring Company

United Therapeutics Corporation

Acquired Company

Anheuser-Busch

Silver SpringWashingtonBiotechnologyHealth CareTherapeuticsManufacturingFood and BeverageHospitalityFood ProcessingMuseums And Historical Sites

Description

United Therapeutics Corporation has acquired a former Anheuser-Busch plant in Merrimack, New Hampshire. This acquisition significantly expands the company's operations in the region. The new property is intended to enhance the company's capacity for organ manufacturing solutions. United Therapeutics plans to utilize the site for its growing footprint in Southern New Hampshire.

Company Information

Company

United Therapeutics Corporation

Location

Silver Spring, Maryland, United States

About

United Therapeutics Corporation is a public benefit corporation focused on saving and improving lives through innovative technologies. The company specializes in expanding the availability of transplantable organs and organ alternatives. With a commitment to groundbreaking accomplishments, United Therapeutics aims to provide life-changing opportunities for patients in need. Through its subsidiary, Lung Bioengineering Inc., the company has innovated methods for lung transplantation.

Don't miss United Therapeutics Corporation's next move

Get an email the moment United Therapeutics Corporation makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Samantha
Senior decision-maker at this company
••••••••@••••••••

See Samantha's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for United Therapeutics Corporation's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Anheuser-Busch?

Anheuser-Busch was acquired by United Therapeutics Corporation, based in Silver Spring. The deal was reported on September 3, 2026. United Therapeutics Corporation is a public benefit corporation focused on saving and improving lives through innovative technologies. United Therapeutics Corporation is publicly traded (UTHR) and operates in Biotechnology.

When did United Therapeutics Corporation acquire Anheuser-Busch?

United Therapeutics Corporation's acquisition of Anheuser-Busch was reported on September 3, 2026. United Therapeutics Corporation has acquired a former Anheuser-Busch plant in Merrimack, New Hampshire. This acquisition significantly expands the company's operations in the region. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Anheuser-Busch do?

Anheuser-Busch always dreams big. It’s our culture and our heritage. But more than that, it’s our future. Learn more about how we are making meaningful impact and bringing our purpose to life. It is publicly traded (BUD), operating in Manufacturing, and is based in Washington.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.